ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00101114
Recruitment Status : Completed
First Posted : January 10, 2005
Last Update Posted : February 28, 2013
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2006
  Study Completion Date : No date given